Article
DNA-Based Deep Learning and Association Studies for Drug Response Prediction in Leiomyosarcoma
2025-10-24
Abstract excerpt
Leiomyosarcoma (LMS) is a rare and aggressive soft tissue sarcoma with limited treatment options and poor prognosis. Standard therapies, including doxorubicin, gemcitabine, trabectedin, and pazopanib, demonstrate variable efficacy across patients, underscoring the need for predictive biomarkers and computational models to inform personalized therapy. We developed a deep learning framework using DNA mutation and ex...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6cd99a2f-0e68-5b87-916b-9a1a426439b8
- DOI
- 10.1101/2025.10.22.25338578
